HUBS Stock Analysis: HubSpot | NYSE
Software - Application | NYSE, USA | Market Cap: 9.011m USD | 12M Return: -66.7% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 392M
Qual. Beats: 1
Rev. Trend: 99.9%
Qual. Beats: 8
Warnings
Tailwinds
Seasonality
HubSpot, Inc. (NYSE: HUBS) is a cloud-based customer relationship management (CRM) software provider headquartered in Cambridge, Massachusetts. Founded in 2005 and publicly traded since its 2014 IPO, the company operates within the Application Software sub-industry of the Information Technology sector, offering its platform on a software-as-a-service (SaaS) subscription model that is standard across the industry.
The companys platform is built around several integrated Hubs. Marketing Hub covers marketing automation, email, social media, SEO, and analytics; Sales Hub provides email tracking, meeting scheduling, pipeline management, and forecasting tools; Service Hub supports customer engagement and support workflows; and Content Hub enables website creation, blogging, video and podcast hosting, and landing pages.
HubSpot also offers Operations Hub for data sync and automation, Commerce Hub for B2B quoting, invoicing, and subscription management, and Breeze, an AI layer that includes an assistant and AI agents designed to automate tasks across the customer journey. The platform is primarily targeted at mid-market business-to-business (B2B) companies across the Americas, Europe, and the Asia Pacific.
In addition to its software products, HubSpot provides professional services, customer success management, and multi-channel support, complementing its core subscription revenue with services that help customers adopt and expand their use of the platform.
- Subscription revenue growth drives consensus beat
- Breeze AI adoption accelerates customer expansion
- Mid-market demand softness pressures new customer adds
| Net Income: 100.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.18 > 0.02 and ΔFCF/TA 5.07 > 1.0 |
| NWC/Revenue: 28.02% < 20% (prev 38.06%; Δ -10.04% < -1%) |
| CFO/TA 0.21 > 3% & CFO 798.0m > Net Income 100.3m |
| Net Debt (-1.44b) to EBITDA (261.8m): -5.51 < 3 |
| Current Ratio: 1.61 > 1.5 & < 3 |
| Outstanding Shares: last quarter (52.6m) vs 12m ago 0.81% < -2% |
| Gross Margin: 83.65% > 18% (prev 84.83%; Δ -1.18% > 0.5%) |
| Asset Turnover: 85.37% > 50% (prev 69.92%; Δ 15.45% > 0%) |
| Interest Coverage Ratio: 250.2 > 6 (EBIT TTM 119.1m / Interest Expense TTM 476k) |
| A: 0.24 (Total Current Assets 2.44b - Total Current Liabilities 1.52b) / Total Assets 3.83b |
| B: -0.19 (Retained Earnings -721.3m / Total Assets 3.83b) |
| C: 0.03 (EBIT TTM 119.1m / Avg Total Assets 3.86b) |
| D: 1.09 (Book Value of Equity 2.00b / Total Liabilities 1.83b) |
| Altman-Z'' = 2.32 = BBB |
| DSRI: 1.00 (Receivables 354.9m/294.5m, Revenue 3.30b/2.72b) |
| GMI: 1.01 (GM 84.83% / 83.65%) |
| AQI: 1.13 (AQ_t 0.27 / AQ_t-1 0.24) |
| SGI: 1.21 (Revenue 3.30b / 2.72b) |
| TATA: -0.18 (NI 100.3m - CFO 798.0m) / TA 3.83b) |
| Beneish M = -2.81 (Cap -4..+1) = A |
As of June 29, 2026, the stock is trading at USD 185.47 with a total of 2,821,114 shares traded. Over the past week, the price has changed by +5.36%, over one month by -6.71%, over three months by -22.01% and over the past year by -66.68%.
Current recommended Stop Loss: 166.00 (which is 10.5% or 1.5 ATR below the current price).
HubSpot has received a consensus analysts rating of 4.42. Therefore, it is recommended to buy HUBS.
- StrongBuy: 20
- Buy: 11
- Hold: 5
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 280.2 | 51.1% |
P/E Trailing = 92.6474
P/E Forward = 13.7174
P/S = 2.7322
P/B = 4.5128
P/EG = 0.2802
Revenue TTM = 3.30b USD
EBIT TTM = 119.1m USD
EBITDA TTM = 261.8m USD
Long Term Debt = 210.2m USD (estimated: total debt 247.3m - short term 37.1m)
Short Term Debt = 37.1m USD (from shortTermDebt, last quarter)
Debt = 247.3m USD (from shortLongTermDebtTotal, last quarter) (leases 247.3m already included)
Net Debt = -1.44b USD (calculated: Debt 247.3m - CCE 1.69b)
Enterprise Value = 7.57b USD (9.01b + Debt 247.3m - CCE 1.69b)
Interest Coverage Ratio = 250.2 (Ebit TTM 119.1m / Interest Expense TTM 476k)
EV/FCF = 10.97x (Enterprise Value 7.57b / FCF TTM 689.7m)
FCF Yield = 9.11% (FCF TTM 689.7m / Enterprise Value 7.57b)
FCF Margin = 20.91% (FCF TTM 689.7m / Revenue TTM 3.30b)
Net Margin = 3.04% (Net Income TTM 100.3m / Revenue TTM 3.30b)
Gross Margin = 83.65% ((Revenue TTM 3.30b - Cost of Revenue TTM 539.1m) / Revenue TTM)
Gross Margin QoQ = 83.46% (prev 83.73%)
Tobins Q-Ratio = 1.98 (Enterprise Value 7.57b / Total Assets 3.83b)
Interest Expense / Debt = 0.19% (Interest Expense 476k / Debt 247.3m)
Taxrate = 15.49% (18.4m / 118.6m)
NOPAT = 100.7m (EBIT 119.1m * (1 - 15.49%))
Current Ratio = 1.55 (Total Current Assets 2.44b / Total Current Liabilities 1.57b)
Debt / Equity = 0.12 (Debt 247.3m / totalStockholderEquity, last quarter 2.00b)
Debt / EBITDA = -5.51 (Net Debt -1.44b / EBITDA 261.8m)
Debt / FCF = -2.09 (Net Debt -1.44b / FCF TTM 689.7m)
Total Stockholder Equity = 2.00b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.60% (Net Income 100.3m / Total Assets 3.83b)
RoE = 5.02% (Net Income TTM 100.3m / Total Stockholder Equity 2.00b)
RoCE = 5.40% (EBIT 119.1m / Capital Employed (Equity 2.00b + L.T.Debt 210.2m))
RoIC = 4.61% (NOPAT 100.7m / Invested Capital 2.18b)
WACC = 9.09% (E(9.01b)/V(9.26b) * Re(9.34%) + D(247.3m)/V(9.26b) * Rd(0.19%) * (1-Tc(0.15)))
Discount Rate = 9.34% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 68.89 | Cagr: 1.95%
[DCF] Terminal Value 75.60% ; FCFF base≈615.4m ; Y1≈705.5m ; Y5≈1.04b
[DCF] Fair Price = 298.0 (EV 13.8b - Net Debt -1.44b = Equity 15.3b / Shares 51.2m; r=9.09% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 1.10 | # QB: 1
Revenue Correlation: 99.92 | Revenue CAGR: 20.54% | SUE: 2.05 | # QB: 8
EPS current Quarter (2026-06-30): EPS=3.02 | Chg30d=+0.00% | Revisions=+76% | Analysts=30
EPS next Quarter (2026-09-30): EPS=3.45 | Chg30d=+0.00% | Revisions=+71% | Analysts=30
EPS current Year (2026-12-31): EPS=13.12 | Chg30d=-0.00% | Revisions=+89% | GrowthEPS=+35.2% | GrowthRev=+18.4%
EPS next Year (2027-12-31): EPS=15.61 | Chg30d=+0.04% | Revisions=+43% | GrowthEPS=+19.1% | GrowthRev=+15.6%
[Analyst] Revisions Ratio: +89%